These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33780368)

  • 1. Impact of the Severity of Alzheimer's Disease on the Quality of Life, Activities of Daily Living, and Caregiving Costs for Institutionalized Patients on Anti-Alzheimer Medications in Japan.
    Ashizawa T; Igarashi A; Sakata Y; Azuma M; Fujimoto K; Kobayashi T; Takase Y; Ikeda S
    J Alzheimers Dis; 2021; 81(1):367-374. PubMed ID: 33780368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of the quality of life in Alzheimer's disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer's disease scale.
    Matsui T; Nakaaki S; Murata Y; Sato J; Shinagawa Y; Tatsumi H; Furukawa TA
    Dement Geriatr Cogn Disord; 2006; 21(3):182-91. PubMed ID: 16401890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study.
    Nakanishi M; Igarashi A; Ueda K; Brnabic AJM; Treuer T; Sato M; Kahle-Wrobleski K; Meguro K; Yamada M; Mimura M; Arai H
    J Alzheimers Dis; 2020; 74(1):127-138. PubMed ID: 31985460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and Resource Use Associated with Alzheimer's Disease in Italy: Results from an Observational Study.
    Bruno G; Mancini M; Bruti G; Dell'Agnello G; Reed C
    J Prev Alzheimers Dis; 2018; 5(1):55-64. PubMed ID: 29405234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of rivastigmine on costs and on time spent in caregiving for families of patients with Alzheimer's disease.
    Marin D; Amaya K; Casciano R; Puder KL; Casciano J; Chang S; Snyder EH; Cheng I; Cuccia AJ
    Int Psychogeriatr; 2003 Dec; 15(4):385-98. PubMed ID: 15000418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross sectional observational study on the societal costs of Alzheimer's disease.
    Mesterton J; Wimo A; By A; Langworth S; Winblad B; Jönsson L
    Curr Alzheimer Res; 2010 Jun; 7(4):358-67. PubMed ID: 19939223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.
    Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW
    BMC Geriatr; 2016 Nov; 16(1):195. PubMed ID: 27887645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Quality of Life, Economic Burden, and Independence Across the Alzheimer's Disease Continuum Using Patient-Caregiver Dyad Surveys.
    Tahami Monfared AA; Khachatryan A; Hummel N; Kopiec A; Martinez M; Zhang R; Zhang Q
    J Alzheimers Dis; 2024; 99(1):191-206. PubMed ID: 38640156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease.
    Reed C; Belger M; Vellas B; Andrews JS; Argimon JM; Bruno G; Dodel R; Jones RW; Wimo A; Haro JM
    Int Psychogeriatr; 2016 Feb; 28(2):247-59. PubMed ID: 26307191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings.
    Heßmann P; Seeberg G; Reese JP; Dams J; Baum E; Müller MJ; Dodel R; Balzer-Geldsetzer M
    J Alzheimers Dis; 2016; 51(2):545-61. PubMed ID: 26890754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease?
    Reed C; Barrett A; Lebrec J; Dodel R; Jones RW; Vellas B; Wimo A; Argimon JM; Bruno G; Haro JM
    Health Qual Life Outcomes; 2017 Jan; 15(1):16. PubMed ID: 28109287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient- and proxy-reported utility in Alzheimer disease using the EuroQoL.
    Jönsson L; Andreasen N; Kilander L; Soininen H; Waldemar G; Nygaard H; Winblad B; Jönhagen ME; Hallikainen M; Wimo A
    Alzheimer Dis Assoc Disord; 2006; 20(1):49-55. PubMed ID: 16493236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between severity of Alzheimer's disease and costs of caring.
    Hux MJ; O'Brien BJ; Iskedjian M; Goeree R; Gagnon M; Gauthier S
    CMAJ; 1998 Sep; 159(5):457-65. PubMed ID: 9757169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia.
    Andersen CK; Wittrup-Jensen KU; Lolk A; Andersen K; Kragh-Sørensen P
    Health Qual Life Outcomes; 2004 Sep; 2():52. PubMed ID: 15383148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proxy-rated quality of life in Alzheimer's disease: a three-year longitudinal study.
    Vogel A; Bhattacharya S; Waldorff FB; Waldemar G
    Int Psychogeriatr; 2012 Jan; 24(1):82-9. PubMed ID: 21729415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and resource use of community-dwelling patients with Alzheimer's disease in Japan: 18-month results from the GERAS-J study.
    Nakanishi M; Igarashi A; Ueda K; Brnabic AJM; Matsumura T; Meguro K; Yamada M; Mimura M; Arai H; Treuer T
    Curr Med Res Opin; 2021 Aug; 37(8):1331-1339. PubMed ID: 33904362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study.
    Olazarán J; Agüera-Ortiz L; Argimón JM; Reed C; Ciudad A; Andrade P; Dilla T
    Int Psychogeriatr; 2017 Dec; 29(12):2081-2093. PubMed ID: 28720158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease severity and its association with patient and caregiver quality of life in Japan: results of a community-based survey.
    Montgomery W; Goren A; Kahle-Wrobleski K; Nakamura T; Ueda K
    BMC Geriatr; 2018 Jun; 18(1):141. PubMed ID: 29898679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between changes in quality of life outcomes and progression of Alzheimer's disease: results from the dependence in AD in England 2 longitudinal study.
    Trigg R; Jones RW; Knapp M; King D; Lacey LA;
    Int J Geriatr Psychiatry; 2015 Apr; 30(4):400-8. PubMed ID: 24920081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caregivers' assessments of preference-based quality of life in Alzheimer's disease.
    Karlawish JH; Zbrozek A; Kinosian B; Gregory A; Ferguson A; Low DV; Glick HA
    Alzheimers Dement; 2008 May; 4(3):203-11. PubMed ID: 18631969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.